275 related articles for article (PubMed ID: 38611591)
1. Cutaneous Intravascular Hematolymphoid Entities: A Review.
Marshall EH; Brumbaugh B; Holt A; Chen ST; Hoang MP
Diagnostics (Basel); 2024 Mar; 14(7):. PubMed ID: 38611591
[TBL] [Abstract][Full Text] [Related]
2. Intralymphatic cutaneous anaplastic large cell lymphoma/lymphomatoid papulosis: expanding the spectrum of CD30-positive lymphoproliferative disorders.
Samols MA; Su A; Ra S; Cappel MA; Louissant A; Knudson RA; Ketterling RP; Said J; Binder S; Harris NL; Feldman AL; Kim J; Kim YH; Gratzinger D
Am J Surg Pathol; 2014 Sep; 38(9):1203-11. PubMed ID: 24805854
[TBL] [Abstract][Full Text] [Related]
3. Intralymphatic CD30+ T-cell proliferation during DRESS: a mimic of intravascular lymphoma.
Weingertner N; Mitcov M; Chenard MP; Cribier B
J Cutan Pathol; 2016 Nov; 43(11):1036-1040. PubMed ID: 27433889
[TBL] [Abstract][Full Text] [Related]
4. Benign atypical intravascular CD30+ T-cell proliferation: a recently described reactive lymphoproliferative process and simulator of intravascular lymphoma: report of a case associated with lichen sclerosus and review of the literature.
Kempf W; Keller K; John H; Dommann-Scherrer C
Am J Clin Pathol; 2014 Nov; 142(5):694-9. PubMed ID: 25319987
[TBL] [Abstract][Full Text] [Related]
5. Intravascular Cutaneous Disorders. A Clinicopathologic Review.
Vilas Boas P; Cerroni L; Requena L
Am J Dermatopathol; 2021 Feb; 43(2):119-136. PubMed ID: 32618704
[TBL] [Abstract][Full Text] [Related]
6. Benign atypical intravascular CD30(+) T-cell proliferation: a reactive condition mimicking intravascular lymphoma.
Riveiro-Falkenbach E; Fernández-Figueras MT; Rodríguez-Peralto JL
Am J Dermatopathol; 2013 Apr; 35(2):143-50. PubMed ID: 23542715
[TBL] [Abstract][Full Text] [Related]
7. Differentiating Intralymphatic Histiocytosis, Intravascular Histiocytosis, and Subtypes of Reactive Angioendotheliomatosis: Review of Clinical and Histologic Features of All Cases Reported to Date.
Mazloom SE; Stallings A; Kyei A
Am J Dermatopathol; 2017 Jan; 39(1):33-39. PubMed ID: 28027079
[TBL] [Abstract][Full Text] [Related]
8. Intralymphatic Proliferation of T-cell Lymphoid Blasts in the Setting of Hidradenitis Suppurativa.
Calamaro P; Cerroni L
Am J Dermatopathol; 2016 Jul; 38(7):536-40. PubMed ID: 26844617
[TBL] [Abstract][Full Text] [Related]
9. Intravascular NK/T-Cell Lymphoma: What We Know about This Diagnostically Challenging, Aggressive Disease.
Zanelli M; Parente P; Sanguedolce F; Zizzo M; Palicelli A; Bisagni A; Carosi I; Trombetta D; Mastracci L; Ricci L; Pancetti S; Martino G; Broggi G; Caltabiano R; Cavazza A; Ascani S
Cancers (Basel); 2022 Nov; 14(21):. PubMed ID: 36358876
[TBL] [Abstract][Full Text] [Related]
10. Gamma/Delta Phenotype in Primary Cutaneous T-cell Lymphomas and Lymphoid Proliferations: Challenges for Diagnosis and Classification.
Torres-Cabala CA; Huen A; Iyer SP; Miranda RN
Surg Pathol Clin; 2021 Jun; 14(2):177-194. PubMed ID: 34023099
[TBL] [Abstract][Full Text] [Related]
11. Intravascular NK/T-cell lymphoma: a report of five cases with cutaneous manifestation from China.
Wang L; Chen S; Ma H; Shi D; Huang C; Lu C; Gao T; Wang G
J Cutan Pathol; 2015 Sep; 42(9):610-7. PubMed ID: 25931234
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous Intravascular CD-30-Positive Anaplastic Large Cell Lymphoma: A Case Report and Literature Review.
Banafshay K; Maldonado D; Tarbox M
Cureus; 2023 Aug; 15(8):e44450. PubMed ID: 37791178
[TBL] [Abstract][Full Text] [Related]
13. Pembrolizumab-induced benign atypical intralymphatic CD30
Hung WK; Chen CB; Kuo TT; Chen WT
J Dermatol; 2022 Feb; 49(2):e53-e54. PubMed ID: 34580915
[No Abstract] [Full Text] [Related]
14. Primary cutaneous T-cell lymphoma: a review of the most common entities with focus on recent updates.
Saleh JS; Subtil A; Hristov AC
Hum Pathol; 2023 Aug; 138():76-102. PubMed ID: 37307932
[TBL] [Abstract][Full Text] [Related]
15. Intravascular ALK-negative anaplastic large cell lymphoma with localized cutaneous involvement and an indolent clinical course: toward recognition of a distinct clinicopathologic entity.
Metcalf RA; Bashey S; Wysong A; Kim J; Kim YH; Gratzinger D
Am J Surg Pathol; 2013 Apr; 37(4):617-23. PubMed ID: 23480896
[TBL] [Abstract][Full Text] [Related]
16. Primary cutaneous T-cell lymphoma: a review of the most common entities with focus on recent updates.
Saleh JS; Subtil A; Hristov AC
Hum Pathol; 2023 Oct; 140():75-100. PubMed ID: 37802757
[TBL] [Abstract][Full Text] [Related]
17. CD30-Negative Cutaneous T-Cell Lymphomas Other than Mycosis Fungoides.
Willemze R
Surg Pathol Clin; 2014 Jun; 7(2):229-52. PubMed ID: 26837200
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous T-cell lymphomas (including rare subtypes). Current concepts. II.
Paulli M; Berti E
Haematologica; 2004 Nov; 89(11):1372-88. PubMed ID: 15531460
[TBL] [Abstract][Full Text] [Related]
19. Primary Cutaneous CD30+ Lymphoproliferative Disorders: a Comprehensive Review.
Di Raimondo C; Parekh V; Song JY; Rosen ST; Querfeld C; Zain J; Martinez XU; Abdulla FR
Curr Hematol Malig Rep; 2020 Aug; 15(4):333-342. PubMed ID: 32435988
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
